4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0000905148-23-000919
Chief Medical Officer sold 2,000 shares at $55.48 ($110,952)
- Chief Medical Officer acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Garren Hideki · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,000 | $24.90 | $49,800 | 2,000 | D |
| 2023-09-13 | Sale : show line 2 in the form 10b5-1 | −2,000 | $55.48 | $110,952 | 0 | D |
| Open-market sales · 2,000 sh · avg $55.48 · $110,952 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-13 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −2,000 | 192,000 | D |
Loading xslF345X05/form4.xml…